Maternal hyperhomocysteinaemia is a risk factor for congenital heart disease

Objective To investigate the inter‐relation between mother and infant homocysteine, folate and vitamin B12 status and the risk of a child with congenital heart disease (CHD). Design Case–control study. Setting Erasmus MC, University Medical Centre, Rotterdam, the Netherlands. Population Particip...

Full description

Saved in:

Bibliographic Details
Published in:	BJOG : an international journal of obstetrics and gynaecology Vol. 113; no. 12; pp. 1412 - 1418
Main Authors:	Verkleij‐Hagoort, AC, Verlinde, M, Ursem, NTC, Lindemans, J, Helbing, WA, Ottenkamp, J, Siebel, FMH, Gittenberger‐de Groot, AC, De Jonge, R, Bartelings, MM, Steegers, EAP, Steegers‐Theunissen, RPM
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01-12-2006 Blackwell Wiley Subscription Services, Inc
Subjects:	Adult Anemia Babies Biological and medical sciences Cardiovascular disease Case-Control Studies Clinical trials Congenital Female folic acid Folic Acid - blood Gynecology. Andrology. Obstetrics heart defects Heart Diseases - congenital homocysteine Homocysteine - blood Humans Hyperhomocysteinemia - complications Infant Maternal Age Medical sciences Mothers Pregnancy Pregnancy Complications risk Risk Factors Statistics, Nonparametric Vitamin B 12 - blood vitamins Mother Gynecology Risk factor Cardiovascular disease Hyperhomocysteinemia Congenital cardiopathy Epidemiology Obstetrics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Objective To investigate the inter‐relation between mother and infant homocysteine, folate and vitamin B12 status and the risk of a child with congenital heart disease (CHD). Design Case–control study. Setting Erasmus MC, University Medical Centre, Rotterdam, the Netherlands. Population Participants were 149 case‐mothers and their children with CHD (n= 151) and 183 control‐mothers with their children (n= 175). Methods Approximately 17 months after the index‐pregnancy maternal fasting, children’s random venous blood samples were drawn to measure plasma total homocysteine, serum and red blood cell (RBC) folate, and serum vitamin B12 concentrations. Data were compared between cases and controls using the Mann–Whitney U test. The biochemical parameters were dichotomised according to the cutoff value of the 10th percentile of vitamin concentrations and the 90th percentile of homocysteine concentrations based on control data. Risk estimates for the association between CHD and the biochemical parameters were estimated in a logistic regression model. Main outcome measures Medians (minimum–maximum) and odds ratios (OR) (95% confidence intervals [CI]). Results The OR (95% CI) of having a child with CHD was 2.9 (1.4–6.0) for maternal hyperhomocysteinaemia (>14.3 μmol/l). This finding is substantiated by a significant concentration‐dependent risk (Ptrend= 0.004). Hyperhomocysteinaemic case‐mothers showed significantly lower serum folate and vitamin B12 concentrations than normohomocysteinaemic case‐mothers. Serum and RBC folate concentrations were significantly higher in case‐children than that in control‐children. Conclusions Maternal hyperhomocysteinaemia is associated with an increased risk of CHD, partially due to low folate and vitamin B12 status. The folate status of children warrants further investigation.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1470-0328 1471-0528
DOI:	10.1111/j.1471-0528.2006.01109.x